Filing Details

Accession Number:
0001455244-10-000145
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-10 16:53:28
Reporting Period:
2010-12-08
Filing Date:
2010-12-10
Accepted Time:
2010-12-10 16:53:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
72444 Nabi Biopharmaceuticals NABI Biological Products, (No Disgnostic Substances) (2836) 591212264
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376960 Jason Aryeh 34 Summer Rd.
Greenwich CT 06831
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-08 4,705 $5.49 181,783 No 4 S Indirect Indirect
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Indirect
Footnotes
  1. The sale reported in this Form 4 was of shares beneficially owned by Jason Aryeh through the Jason Aryeh Trust.
  2. Consists of (i) 17,000 shares owned directly by Mr. Aryeh; and (ii) the remainder of shares benefically owned by Jason Aryeh through his relationship with JALAA Equities, LP, the Jason Aryeh Trust, the Jason Aryeh 2003 Family Trust, and the Jason Aryeh IRA (collectively, the "Aryeh Entities"). Mr. Aryeh disclaims beneficial ownership of all securities held through the Aryeh Entities, except to the extent of any indirect pecuniary interest he may have therein.